Navigation Links
Leading Vaccine Expert Joins IAVI
Date:7/3/2008

NEW YORK, July 3 /PRNewswire-USNewswire/ -- Dr. Thomas Hassell, former global vice president of process development at sanofi pasteur, a leading vaccine company, has joined IAVI as vice president for vaccine development. In his new role, Dr. Hassell will lead IAVI's product development efforts that are aimed at rapidly advancing promising vaccine candidates that emerge from the organization's vaccine discovery programs.

Dr. Hassell is trained as a microbiologist and received his Ph.D. at Manchester Metropolitan University in the United Kingdom in 1987. He completed his post-doctorate program at the Massachusetts Institute of Technology as a Rockefeller Foundation Fellow in 1989. He has 20 years of experience within industry, working for several leading vaccine developers taking early-stage vaccine candidates all the way through to licensure.

"If we are to defeat AIDS once and for all, we need a vaccine. To develop a vaccine, we need to translate promising concepts into candidates that are tested in humans. My job at IAVI is to make this happen as quickly and safely as possible," said Dr. Hassell.

At sanofi pasteur, Dr. Hassell led a team of 250 researchers who developed vaccines that have been licensed worldwide. Most recently, Dr. Hassell assisted in the national licensure of Pentacel, a childhood combination vaccine that protects against diphtheria, tetanus, whooping cough, Haemophilus Influenzae Type B, and polio, and Menactra, the first conjugate vaccine to provide protection against four strains, A,C,Y and W, of bacterial meningitis. Dr. Hassell also oversaw the launch of a series of new, state-of-the-art vaccine development facilities in Canada, France and the United States that have enabled sanofi pasteur to better support their existing vaccine portfolio, as well as to allow more rapid development of their new vaccines.

After a vaccine candidate proves promising in pre-clinical animal studies, many steps are required to tra
'/>"/>

SOURCE International AIDS Vaccine Initiative
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Leading Eating Disorder Treatment Center Identifies Popular Diet Myths
2. Chinas Leading Healthcare Market Player Records 200% Increase in Profits and Earnings
3. Leading Provider of Electronic Medical Records (EMR) Systems for Sleep Centers Adds Field Sales Representative
4. Leading Performance-Enhancing Drug Research Institute Anti-Doping Research (ADR) Establishes Nonprofit Status
5. Leading Fertility Center Adds New Physician
6. Leading Healthcare Organizations Overwhelmingly Select Sentillion for User Provisioning
7. Long-term safety data on Lialda published in leading GI journal
8. Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal
9. DrScore, the Premier Online Patient Satisfaction Service Partners With Leading Healthcare Web Design Firm, Practis, Inc.
10. PartsSource Given 2008 Leading Edge Award for Second Straight Year
11. Front Line Caregiver Coalition Thanks Sens. Conrad, Coleman and Reps. Pomeroy, Capito and Berkley for Leading Bipartisan Hill Effort to Stop Bush Administrations Damaging Medicare Cuts
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 2Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 3Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 4Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 5Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 6Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 7Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 8Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 9Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 10Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 11Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 12Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 13Health News:Fuwei Films Announces Fourth Quarter and Full Year 2007 Financial Results 14Health News:Practice Greenhealth Hires First Exec 2Health News:Gerresheimer Starts the Year Successfully in 2008 2Health News:Gerresheimer Starts the Year Successfully in 2008 3Health News:Gerresheimer Starts the Year Successfully in 2008 4Health News:Northwest Songwriter Dean Backholm Featured on National March of Dimes CD 2Health News:Kent State University Stark Campus to Confer First Class of Nursing Students 2Health News:Clergy Abuse Victims Want UN to Investigate Vatican 2
Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 1Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 2Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 3Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 4Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 5Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 6President Obama Misleads on Abortion Funding in Health Care Reform 54931 1President Obama Misleads on Abortion Funding in Health Care Reform 54931 2Kaiser Workers Launch Statewide Pickets 54929 1